These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2902608)

  • 21. [Bronchodilator treatment of COPD].
    Naberan K
    Aten Primaria; 1998 Feb; 21(2):109-13. PubMed ID: 9608136
    [No Abstract]   [Full Text] [Related]  

  • 22. [Current dosed aerosols in the treatment of obstructive airway diseases. 2. Bronchospasmolytics].
    Krecklow B
    Z Arztl Fortbild (Jena); 1984; 78(1):5-9. PubMed ID: 6231780
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of efficacy and ease of handling of salmeterol and terbutaline powder inhalers.
    Burdon J; Droszcz W; Jones R; Johnston PR; Trowell SJ
    Int J Clin Pract; 1998 Mar; 52(2):85-8. PubMed ID: 9624787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative studies on the oral therapy of obstructive respiratory tract diseases with clenbuterol, fenoterol and depot-orciprenaline (double-blind study)].
    Flohr E; Bischoff KO
    Verh Dtsch Ges Inn Med; 1978; (84):417-20. PubMed ID: 369198
    [No Abstract]   [Full Text] [Related]  

  • 25. Bronchodilator response to oral aminophylline and terbutaline versus aerosol albuterol in patients with chronic obstructive pulmonary disease.
    Shim CS; Williams MH
    Am J Med; 1983 Oct; 75(4):697-701. PubMed ID: 6624778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-over study of the efficacy of four beta 2-sympathomimetic bronchodilator aerosols.
    Madsen BW; Tandon MK; Paterson JW
    Br J Clin Pharmacol; 1979 Jul; 8(1):75-82. PubMed ID: 45195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of delayed-action beta-2 mimetics in the management of chronic obstructive bronchial disease--against].
    Terrioux P
    Rev Mal Respir; 1999 Jan; 16 Suppl 3():S76-7. PubMed ID: 10088258
    [No Abstract]   [Full Text] [Related]  

  • 28. Pressurized bronchodilator aerosol technique: influence of breath-holding time and relationship of inhaler to the mouth.
    Lawford P; McKenzie
    Br J Dis Chest; 1982 Jul; 76(3):229-33. PubMed ID: 7126435
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of a combined treatment theophylline and tulobuterol on nocturnal chronic asthma.
    Rühle KH; Dorow P; Schmitz-Schumann H
    Lung; 1990; 168 Suppl():192-3. PubMed ID: 1974676
    [No Abstract]   [Full Text] [Related]  

  • 30. [The validation and procedure of inhalation therapy using 2-component aerosols in obstructive bronchopulmonary diseases].
    Ivashkin VT; Iakovlev VN; Sinopal'nikov AI; Antokhin EA
    Ter Arkh; 1993; 65(8):44-9. PubMed ID: 8211802
    [No Abstract]   [Full Text] [Related]  

  • 31. Evidence based answers--is salmeterol safe in asthma?
    Spurling G; Doust J
    Aust Fam Physician; 2006 Aug; 35(8):625-6. PubMed ID: 16894440
    [No Abstract]   [Full Text] [Related]  

  • 32. [Efficacy of the simultaneous aerosol administration of fenoterol and 2(alpha-thenoylthio)propionylglycine].
    Ardizzi A; Della Toffola A; Galietti F; Giorgis GE; Miravalle C; Oliaro A; Scappaticci E
    Minerva Med; 1986 Oct; 77(39):1823-6. PubMed ID: 3534632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Beta-2 specificity of bronchially active sympathomimetics using capillary laser Doppler sonography exemplified by tulobuterol].
    Jorde W; Schata M
    Prax Klin Pneumol; 1987 Apr; 41(4):132-5. PubMed ID: 2885821
    [No Abstract]   [Full Text] [Related]  

  • 34. On the effects of aerosol bronchodilator and some problems of ultrasonic nebulization--its pharmacological potency with or without positive pressure.
    Goto Y; Harada J; Sugiura Y
    Z Erkr Atmungsorgane; 1986; 166(1):107-9. PubMed ID: 2869611
    [No Abstract]   [Full Text] [Related]  

  • 35. Eformoterol in elderly patients: a follow-up.
    Brambilla R
    Br J Clin Pract Suppl; 1995 Sep; 81():6-7. PubMed ID: 8546894
    [No Abstract]   [Full Text] [Related]  

  • 36. [Ipratropine and terbutaline. A comparative study of 19 patients with chronic obstructive lung diseases].
    Petersen BN; Weeke E
    Ugeskr Laeger; 1979 Sep; 141(36):2439-42. PubMed ID: 160643
    [No Abstract]   [Full Text] [Related]  

  • 37. New beta-agonist, KWD 2131, compared with terbutaline in asthmatics. A cumulative dose-response study.
    Hegardt B; Löwhagen O; Svedmyr N
    Allergy; 1980 Mar; 35(2):105-12. PubMed ID: 6104451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbuterol, fenoterol, orciprenaline, salbutamol and terbutaline per os in reversible obstructive chronic bronchitis.
    Minette A; Marcq M; Gepts L
    Bull Eur Physiopathol Respir; 1976; 12(4):545-53. PubMed ID: 13895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative clinical data on the bronchodilating effect of some selective beta-2 stimulating drugs].
    Miraglia Del Giudice M; Capristo A; Panico D
    Pediatria (Napoli); 1977 Jun; 85(2):190-205. PubMed ID: 20598
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiopulmonary effects of terbutaline and a bronchodilator combination in chronic obstructive pulmonary disease.
    Pierson DJ; Hudson LD; Stark K; Hedgecock M
    Chest; 1980 Feb; 77(2):176-82. PubMed ID: 6986238
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.